Calreticulin exposure dictates the immunogenicity of cancer cell death;La calréticuline détermine l'immunogénicité de la chimiothérapie et de la radiothérapie antitumorales

Medecine/Sciences

Volumn 23, Issue 3, 2007, Pages 257-258

  Apetoh, Lionel ^a   Ghiringhelli, François ^a   Zitvogel, Laurence ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CALRETICULIN; DOXORUBICIN; GAMMA INTERFERON; IDARUBICIN; MITOMYCIN C; MITOXANTRONE;

ANTINEOPLASTIC ACTIVITY; CANCER CELL; CANCER CELL DESTRUCTION; CANCER CHEMOTHERAPY; CHEMOTHERAPY; DRUG ACTIVITY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; NOTE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 33947509571     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2007233257     Document Type: Note

References (9)

1. Lake RA, van der Most RG. A better way for a cancer cell to die. N Engl J Med 2006 ; 354 : 2503-4.
2. Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 2006 ; 6 : 715-27.
3. Zitvogel L, Casares N, Pequignot MO, Chaput N, Albert ML, Kroemer G. Immune response against dying tumor cells. Adv Immunol 2004 ; 84 : 131-79.
4. Casares N, Pequignot MO, Tesniere A, et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 2005 ; 202 : 1691-701.
5. Obeid M, Tesniere A, Ghiringhelli F, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2006 ; 13 : 54-61.
6. Krause KH, Michalak M. Calreticulin. Cell 1997 ; 88 : 439-43.
7. Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 1996 ; 5 : 103-14.
8. Bedard K, Szabo E, Michalak M, Opas M. Cellular functions of endoplasmic reticulum chaperones calreticulin, calnexin, and ERp57. Int Rev Cytol 2005 ; 245 : 91-121.
9. Gardai SJ, McPhillips KA, Frasch SC, et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 2005 ; 123 : 321-34.